Therapy Areas: Cardiovascular
9 March 2026 - Clinical stage gene editing company Precision BioSciences (Nasdaq:DTIL) announced on Monday that the US Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-D...
5 March 2026 - Digital therapeutics developer GAIA and Daiichi Sankyo Europe, part of Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568), on Thursday announced an exclusive strategic partner...
3 March 2026 - US commercial stage biopharmaceutical company Esperion Therapeutics Inc (NASDAQ:ESPR) on Tuesday announced a definitive agreement to acquire privately held Corstasis Therapeutics Inc, a...
26 February 2026 - Biotechnology company Circio Holding ASA (OSE:CRNA) on Thursday reported new in vivo data showing that its AAV-circVec 4.0 platform achieved up to 50-fold higher gene expression in ...
12 February 2026 - Biotechnology company Celyad Oncology (Euronext Brussels:CYAD) announced on Thursday that it has sold its C-Cathez transendocardial catheter to CellProthera, including all intellect...
11 February 2026 - Artificial heart technology company Scandinavian Real Heart AB (Nasdaq Stockholm First North Growth Market:HEART) announced on Wednesday that it has received patent approval from th...